Skip to main content

Table 2 Maternal characteristics of infants enrolled into the study

From: Intermittent screening and treatment for malaria complementary to routine immunisation in the first year of life in Papua, Indonesia: a cluster randomised superiority trial

 

ISTi (10 clusters)

PCDi (11 clusters)

Total

N = 313

N = 444

N = 757

Age (years)b

26 (6)

25 (6)

25 (6)

Parityb

2 (1, 3)

2 (1, 3)

2 (1, 3)

Parity groupa

 Primiparity

85/311 (27.3)

133/443 (30.0)

218/754 (28.9)

 Multiparity

226/311 (72.7)

310/443 (69.9)

536/754 (71.1)

Socioeconomic statusa

 Low

93/313 (29.7)

177/444 (39.9)

270/757 (35.7)

 Medium

103/313 (32.9)

133/444 (29.9)

236/757 (31.2)

 High

117/313 (37.4)

134/444 (30.2)

251/757 (33.2)

Educationa

 No school

37/294 (12.6)

44/407 (10.8)

81/701 (11.6)

 Primary and secondary school

109/294 (37.1)

203/407 (49.9)

312/701 (44.5)

 High School

14/294 (4.8)

18/407 (4.4)

32/701 (4.6)

 College education

134/294 (45.6)

142/407 (34.9)

276/701 (39.4)

Maternal intervention groupsac

 SST

97/313 (31.1)

142/444 (32.1)

239/757 (31.6)

 IST

147/313 (47.1)

145/444 (32.7)

292/757 (38.6)

 IPT-DHP

69/313 (22.0)

157/444 (35.4)

226/757 (29.9)

Any maternal malaria at antenatal care (any method)a

89/313 (28.4)

132/444 (29.7)

221/757 (29.2)

 P. falciparum

61/313 (19.5)

92/444 (20.7)

153/757 (20.2)

 P. vivax

57/313 (18.2)

92/444 (20.7)

149/757 (19.7)

Peripheral parasitaemia (any method) at deliverya

29/284 (10.2)

46/400 (11.5)

75/684 (11.1)

 P. falciparum

16/283 (5.7)

30/400 (7.5)

46/683 (6.7)

 P. vivax

18/284 (6.3)

35/399 (8.8)

53/683 (7.8)

Any placental malaria infection at deliverya

32/274 (11.7)

50/381 (13.1)

82/655 (12.5)

 P. falciparum

11/282 (3.9)

22/399 (5.5)

33/681 (4.8)

 P. vivax

16/283 (5.7)

31/401 (7.7)

47/684 (6.9)

Any placental or peripheral malaria infection at delivery

50/285 (17.5)

78/401 (19.5)

128/686 (18.7)

Hb and anaemia at enrolment

 Mean Hb (g/dL)b

11.4 (1.8)

11.0 (1.9)

11.2 (1.9)

 Anaemia (Hb < 10 g/dL)a

58/311 (18.6)

113/442 (25.6)

171/753 (22.7)

 Anaemia (Hb < 7 g/dL)a

3/311 (1.0)

14/442 (3.2)

17/753 (2.3)

Hb and anaemia at delivery

 Mean Hb (g/dL)b

11.3 (1.9)

11.2 (2.2)

11.2 (2.1)

 Anaemia (Hb < 10 g/dL)a

54/261 (20.7)

99/367 (27.1)

153/628 (24.4)

 Anaemia (Hb < 7 g/dL)a

2/284 (0.7)

16/400 (4.0)

18/684 (2.6)

Maternal malnutritiona

69/312 (22.1)

90/443 (20.3)

159/755 (21.1)

  1. ISTii intermittent screening and treatment in infants, PCDii passive case detection in infants
  2. aCategorical data are presented as frequency in valid cases (%)
  3. bContinuous data are presented as median (25th percentile, 75th percentile) or mean (SD)
  4. cSSTi single screening and treatment, ISTi intermittent screening and treatment, IPT-DHPi intermittent preventive and treatment with dihydroartemisinin-piperaquine